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ABSTRACT 
S-Acylation of the SNARE protein 
synaptosome-associated protein of 25kDa 
(SNAP25) is mediated by a subset of Golgi 
zinc finger DHHC-type palmitoyltransferase 
(zDHHC) enzymes, particularly zDHHC17. 
The ankyrin repeat (ANK) domain of 
zDHHC17 interacts with a short linear motif 
known as the zDHHC ANK-binding motif 
(zDABM) in SNAP25 (112-VVASQP-117), 
which is downstream of its S-acylated, 
cysteine-rich domain (85-CGLCVCPC-92). 
Here, we investigated the importance of a 
flexible linker region (amino acids 93–111, 
referred to hereafter as the “mini-linker” 
region) that separates the zDABM and S-
acylated cysteines in SNAP25. Shortening the 
mini-linker did not affect the SNAP25–
zDHHC17 interaction but blocked S-acylation. 
Insertion of additional flexible glycine–serine 
repeats had no effect on S-acylation, but 
extended and rigid alanine–proline repeats 
perturbed it. A SNAP25 mutant in which the 
mini-linker region was substituted with a 
flexible glycine–serine linker of the same 
length underwent efficient S-acylation. 
Furthermore, this mutant displayed the same 
intracellular localization as wild-type 
SNAP25, indicating that the amino acid 
composition of the mini-linker is not important 
for SNAP25 localization. Using the results of 
previous peptide array experiments, we 
generated a SNAP25 mutant predicted to have 
a higher-affinity zDABM. This mutant 
interacted with zDHHC17 more strongly, but 
was S-acylated with reduced efficiency in 
HEK293T cells, implying that a lower-affinity 
interaction of the SNAP25 zDABM with 
zDHHC17 is optimal for S-acylation 
efficiency. These results show that amino 
acids 93–111 in SNAP25 act as a flexible 
molecular spacer that ensures efficient 
coupling of the SNAP25–zDHHC17 
interaction and S-acylation of SNAP25. 
      
S-acylation (aka palmitoylation), the reversible 
attachment of fatty acids onto cysteine 
residues, occurs on a wide range of eukaryotic 
proteins (1). This post-translational 
modification regulates membrane interactions 
of soluble proteins and mediates stabilisation 
and trafficking of both soluble and 
transmembrane proteins (2). The occurrence of 
S-acylation is widespread (3,4), with synaptic 
proteins apparently over-represented in the S-
acylated proteome: 41 % of synaptic proteins 
were suggested to be modified by S-acyl 
chains (5). Many of the S-acylated synaptic 
proteins that have been characterised are 
reversibly modified and undergo S-acylation 
cycling mediated by zDHHC S-acyltransferase 
and APT/ABHD thioesterase enzymes 
localised at synaptic regions (5-9). However 
initial S-acylation of newly-synthesised 
synaptically-targeted proteins is likely to occur 
in the cell body, mediated by zDHHC enzymes 
localised to endoplasmic reticulum (ER) or 
Golgi compartments (8). 
There are 23 zDHHC enzyme isoforms in the 
human genome (6). The encoded enzymes are 
transmembrane proteins that are 
predominantly associated with ER and Golgi 
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compartments (10). The catalytic domain of 
zDHHC enzymes is a 51-amino acid cysteine-
rich domain containing an aspartate-histidine-
histidine-cysteine (DHHC) motif. The S-
acylation reaction occurs via a two-step 
process whereby the cysteine of the DHHC 
motif undergoes autoacylation prior to transfer 
of the acyl chain to substrate cysteine (11,12). 
The catalytic cysteine of zDHHC enzymes is 
positioned at the cytosolic face of the 
membrane (13,14) and therefore substrate 
cysteines must be at a similar position to allow 
S-acylation. Although palmitic acid is the 
main fatty acid used in S-acylation reactions, 
zDHHC enzymes can also use shorter and 
longer chain fatty acids as substrates (15). The 
fatty acid selectivity of these enzymes is 
determined by specific amino acids in the 
transmembrane domains that determine the 
length of acyl chain that can be accommodated 
within the tepee-like cavity formed by the 
transmembrane helices (11,14,16). 
Although zDHHC enzymes were recognised 
as S-acyltransferases over fifteen years ago 
(6), there is very little information available 
about the substrate networks of individual 
enzymes and how enzyme-substrate specificity 
is encoded. Some zDHHC enzymes, such as 
zDHHC3 and zDHHC7 appear to exhibit very 
loose substrate specificity and may have 
minimal interactions with their substrates (17). 
Instead these enzymes may rely on a very high 
intrinsic activity to mediate S-acylation of any 
accessible cysteines at the membrane interface 
(17). In contrast, some other zDHHC enzymes 
exhibit a much more restricted substrate 
network. zDHHC17 and zDHHC13 are unique 
in the zDHHC family as they contain an N-
terminal ankyrin-repeat (ANK) domain. ANK 
domains are present in many different proteins 
and are recognised as protein interaction 
modules. The ANK domain of zDHHC17 is 
essential for S-acylation of substrates such as 
huntingtin, synaptosomal-associated protein of 
25 kDa (SNAP25) and cysteine-string protein 
(CSP) (17,18). Our previous work identified a 
consensus recognition short linear motif 
(SLiM) in these and other substrates that 
mediate binding to the ANK domain of both 
zDHHC17 and zDHHC13 (19). The 6-amino 
acid [VIAP][VIT]XXQP consensus motif 
makes key contacts with asparagine-100 and 
tryptophan-130 of zDHHC17 (20). We named 
the consensus SLiM the “zDHHC Ankyrin 
repeat Binding Motif (zDABM)” (21). The 
affinity of the SNAP25 zDABM for the ANK 
domain of zDHHC17 is ~11 M, although 
full-length SNAP25 has a higher affinity (0.5 
M) (20), likely owing to optimisation of 
binding/presentation of the zDABM to 
zDHHC17. The presence of other zDHHC17 
binding sites in SNAP25 is unlikely as 
mutation of proline-117 in the zDABM blocks 
binding to the ANK domain, S-acylation and 
membrane targeting (19,22,23). 
Using peptide arrays, we defined the sequence 
rules of the zDABM of SNAP25 and CSP and 
used these rules to predict and validate a 
number of new zDHHC17 interactors (21). 
This analysis suggested that different 
zDABMs have different affinities for the ANK 
domain of zDHHC17 and that this can also be 
influenced by the identity of non-conserved 
residues (i.e. ‘X’ position in the zDABM) or 
surrounding amino acids (21). Furthermore, 
using the generated sequence rules of 
interaction, it was possible to create zDABM 
sequences that displayed increased interactions 
with the ANK domain of zDHHC17 (21). An 
interesting observation that came from this 
analysis is that not all of proteins that contain 
zDABMs are S-acylated by zDHHC17 (21), 
suggesting that other features of the binding 
partner must dictate whether or not it is an 
effective S-acylation substrate. Although the 
crystal structure of the ANK domain of 
zDHHC17 (with and without substrate 
peptide) has been reported (20), there is 
currently no structural information available 
for the full-length enzyme. Thus, it is unclear 
how the substrate-binding ANK domain and 
the catalytic DHHC domain of zDHHC17 are 
positioned relative to each other. Unlike other 
zDHHC enzymes, zDHHC17 and zDHHC13 
are predicted to contain six (rather than four) 
transmembrane domains (24) and it is likely 
that the additional two transmembrane helices 
play some role in mediating the correct 
positioning of the ANK domain relative to the 
bilayer and DHHC domain. 
Our hypothesis is that substrates of zDHHC17 
require both a zDABM and also accessible 
cysteine residues that are appropriately 
positioned to allow simultaneous engagement 
of the zDABM with the ANK domain and the 
cysteines with the DHHC domain. Thus, the 
relative orientations and spatial separation of 
the ANK domain and catalytic DHHC domain 
of zDHHC17 must be mirrored in the zDABM 
and cysteines of substrate proteins to allow 
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effective S-acylation. We also propose that the 
affinity of the zDABM-ANK domain 
interaction is suitably optimised to allow both 
efficient substrate engagement and release 
following S-acylation. In this study, we have 
tested these ideas by modifying the mini-linker 
region of SNAP25 that connects the zDABM 
and S-acylated cysteines. The results suggest 
that the sequence of the linker is not important 
for efficient S-acylation by zDHHC17 but that 
linker length and flexibility are important 
features for S-acylation. In addition, we have 
used knowledge about the zDABM-ANK 
domain interaction to generate a SNAP25 
mutant which displays enhanced binding to 
zDHHC17. This mutant displays reduced S-
acylation by zDHHC17 in HEK293T cells, 
demonstrating the importance of binding 
affinity for S-acylation efficiency. 
 
RESULTS 
Shortening the mini-linker region between 
the S-acylation domain and the zDABM of 
SNAP25 has no effect on zDHHC17 
interaction but blocks S-acylation 
The linker domain of SNAP25 is the region of 
the protein that separates the two SNARE 
domains (25). This ~60 amino acid region 
includes the S-acylated cysteines (amino acids 
85-92) and the zDABM (amino acids 112-
117). In this study, we were interested in the 
region of SNAP25 separating the cysteine-rich 
domain and zDABM (i.e. residues 93-111) and 
refer to this region herein as the “mini linker” 
(Figure 1A). 
In previous work, we reported that shortening 
the mini-linker of SNAP25 led to a loss of 
membrane association induced by zDHHC17 
co-expression (23). To investigate this further, 
we examined S-acylation of a range of 
SNAP25 mutants with deletions of between 4 
and 8 amino acids from the mini-linker. S-
acylation was assessed by incubating 
transfected cells in C16:0-azide, and proteins 
incorporating the azide were subsequently 
labelled using click chemistry with an alkyne 
infrared dye. As shown in Figure 1A, there 
was a marked and significant loss of S-
acylation when 5 or more amino acids were 
removed, with deletion of 8 amino acids 
having the greatest effect. This loss of S-
acylation was specific to zDHHC17 and was 
not observed with the high activity/low 
selectivity enzyme, zDHHC7 (Figure 1B). 
These results are consistent with our previous 
demonstration of a loss of membrane binding 
of these mutants when co-expressed with 
zDHHC17 (23). To examine if loss of S-
acylation was associated with loss of binding 
to zDHHC17, we undertook 
immunoprecipitation (IP) experiments (Figure 
1C). As shown, IP of EGFP-SNAP25 led to 
co-immunoprecipitation (co-IP) of HA-
zDHHC17. A similar result was seen with the 
SNAP25 (101-108) mutant, suggesting that 
deletion of these residues from the mini-linker 
has no effect on interaction of SNAP25 with 
zDHHC17 in HEK293T cells. In contrast, 
substitution of proline-117 in the zDABM of 
SNAP25 with a glycine residue led to a 
complete loss of co-IP of HA-zDHHC17, 
which demonstrates that this approach 
faithfully reports on interactions of zDHHC17 
with the zDABM of SNAP25 (proline-117 is 
essential for this interaction) (19). To confirm 
that the C16:0-azide was attached to cysteine 
residues in both the WT and 101-108) 
mutant, cell lysates were treated without or 
with 1M hydroxylamine, which cleaves 
thioesters; although this treatment led to some 
loss of immunoreactivity, there was clearly a 
loss of click signal (Figure 1D), consistent 
with C16:0-azide on both proteins being linked 
by hydroxylamine-sensitive thioester bonds. 
mPEG-Click reveals the number of S-
acylated cysteines on SNAP25 proteins 
SNAP25 has 4 potential S-acylated cysteines. 
The reduction in click chemistry signal using 
alkyne infrared dye (Figure 1) could therefore 
reflect any of the following: (i) a reduction in 
the total number of SNAP25 molecules that 
are S-acylated; (ii) a reduction in the number 
of cysteines that are modified on individual 
SNAP25 molecules; or (iii) a combination of 
(i) and (ii). We therefore sought to implement 
a different click chemistry labelling approach 
that would allow these possibilities to be 
discriminated. For this, instead of reacting 
C16:0-azide with an alkyne infrared dye, we 
instead reacted it with a 5kDa PEG Alkyne 
(Alk-mPEG) and characterised this 
methodology using cells transfected with 
EGFP-SNAP25 and HA-zDHHC7. As can be 
seen in Figure 2A, this approach allowed 
visualisation of four distinct PEGylated bands 
for SNAP25 (labelled 1-4). To confirm that 
these immunoreactive bands represent 
SNAP25 modified by 1-4 mPEG groups (and 
hence SNAP25 S-acylated on 1-4 cysteines) 
we showed that: (i) these PEGylated bands 
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were lost when all four cysteines in SNAP25 
were mutated to leucines (Figure 2B); (ii) 
PEGylated bands were not observed with a 
catalytically-dead zDHHC7(C160A) mutant 
(Figure 2C); and (iii) there was a 
corresponding loss of the upper PEGylated 
band when one cysteine was mutated and a 
loss of the upper two PEGylated bands when 
two cysteines were mutated in SNAP25 
(Figures 2D and 2E). As well as providing a 
methodology to more thoroughly investigate 
S-acylation of SNAP25, to our knowledge, this 
analysis also provides the first direct evidence 
that SNAP25 can be modified simultaneously 
on all four of its cysteines. Finally, we 
compared the S-acylation profile of SNAP25 
when co-expressed with DHHC7 versus 
DHHC17 (Figure 2F). The WT SNAP25 
protein appeared to be modified differently by 
zDHHC7 and zDHHC17; the amount of 
SNAP25 modified with 2 or 3 mPEG groups 
was lower with zDHHC17 than with 
zDHHC7. mPEG-Click therefore reveals that 
SNAP25 is less heavily S-acylated by 
zDHHC17 than by zDHHC7, which is 
consistent with zDHHC17 being a low activity 
/ high selectivity enzyme and zDHHC7 a high 
activity / low selectivity enzyme (17). 
Although a higher molecular weight SNAP25 
band was present with zDHHC17 co-
expression that migrated at the same size as 
SNAP25 modified by four mPEG groups, this 
band was present in both the absence and 
presence of C16:0-azide labelling (compare “-
” and “+” Az-C16:0 samples), and thus is not a 
PEGylated form of the protein. Instead, we 
believe that this is an aggregated form of 
SNAP25 that arises due to incomplete S-
acylation by zDHHC17. 
We then studied the S-acylation profile of 
EGFP-SNAP25 WT and mini-linker deletion 
mutants when co-expressed with zDHHC7 or -
17 using the newly characterised mPEG-Click 
technique. The mPEG-Click results were 
consistent with the results obtained with the 
alkyne infrared dye click technique, and the 
deletions had little effect on S-acylation 
catalysed by zDHHC7 (Figure 3A). In 
contrast, for S-acylation mediated by 
zDHHC17, the progressive shortening of the 
linker region induced an equally progressive 
disappearance of the PEGylated bands, 
consistent with a reduction in S-acylation 
(Figure 3A). Our hypothesis is that this loss of 
S-acylation occurs due to reduced accessibility 
of cysteines in SNAP25 to the active site of 
zDHHC17 (i.e. that the binding site and 
catalytic site of zDHHC17 are separated by a 
minimal distance, which also requires a 
minimal separation of the zDABM and 
cysteine-rich domain of SNAP25). We 
reasoned that cysteines in SNAP25 that are 
closer to the zDABM (e.g. C92) should 
become inaccessible to the zDHHC17 active 
site before cysteines that are further away from 
the zDABM (e.g. C85) as the mini-linker is 
shortened. To test this, we introduced C-to-L 
mutations within two of the deletion mutants 
that showed a partial but not complete loss of 
S-acylation by zDHHC17 (∆(101-105) and 
∆(101-106); Figure 1A). The cysteines in 
SNAP25 were replaced with leucine residues 
rather than alanine or serine as our previous 
work showed that the hydrophobicity of the 
cysteines is important for initial membrane 
interaction of SNAP25 prior to S-acylation. 
This hydrophobicity is preserved by leucine 
substitutions but not alanine or serine (26). 
Either the first cysteine of the S-acylation 
domain (C85) or the last one (C92) were 
therefore mutated to leucine. Interestingly, 
when co-expressed with zDHHC17, the C85L 
mutation had more impact on the S-acylation 
profile of both of the deletion mutants than the 
C92L mutation (Figure 3B), showing that Cys-
85 is more efficiently S-acylated within the 
deletion mutants than Cys-92. This was clearly 
different from WT SNAP25, in which the 
C92L mutation decreased S-acylation by 
zDHHC17 more than the C85L mutation 
(Figure 3B). Overall, these results suggest that 
Cys-92 becomes more inaccessible for S-
acylation when the mini-linker sequence is 
shortened, consistent with it being closer to the 
zDABM zDHHC17 binding site. 
Efficient S-acylation of SNAP25 is disrupted 
by introducing structure into the mini-linker 
sequence 
As S-acylation was disrupted by introducing 
short deletions to the mini-linker region of 
SNAP25, we investigated if inserting 
additional amino acids was also disruptive. 
The zDABM and mini-linker region of 
SNAP25 are disordered (19,27) and when 
disorder was maintained through the insertion 
of a 10-amino acid (G4S)2 flexible sequence 
(GGGGSGGGGS) (28), there was no effect on 
S-acylation mediated by zDHHC7 and a very 
slight but significant increase in S-acylation by 
zDHHC17 (Figure 4A). In contrast, when a 
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more rigid amino acid sequence was 
introduced at the same position within 
SNAP25, consisting of Ala-Pro repeats 
(SNAP25b (AP)2, (AP)4 and (AP)6) (28), there 
was a clear effect on S-acylation mediated by 
zDHHC17 but not zDHHC7 (Fig 4B). 
Specifically, the insertion of the 8 amino acid 
sequence (AP)4 or of the 12 amino acid 
sequence (AP)6 significantly decreased 
SNAP25 S-acylation, consistent with a 
displacement of the S-acylation site from the 
active site of zDHHC17. We also confirmed 
that the bond linking the C16:0-azide to the 
(AP)6 mutant protein was a thioester as 
hydroxylamine treatment induced its 
hydrolysis (Figure 4C). 
Together with the previous data, we can 
conclude that the distance between the S-
acylation domain and the zDABM sequence of 
SNAP25b is critical for its S-acylation by 
zDHHC17, and that whereas additional 
flexible amino acid sequences are tolerated, 
rigid sequences that introduce structural 
constraints are inhibitory.  
Replacing the mini-linker region with a 
flexible linker does not affect SNAP25 S-
acylation by zDHHC17 
The previous analyses have shown that the 
length of the mini-linker sequence is an 
important factor for efficient S-acylation of 
SNAP25 by zDHHC17. To examine if the 
sequence of the mini-linker is also important, 
this region (93-111) was entirely replaced with 
a glycine-serine (GS) linker of the same length 
(Figure 5A). Unexpectedly, this mutant 
showed a partial loss of S-acylation mediated 
by zDHHC7, which might reflect a difference 
in membrane affinity (see Discussion). 
However, this replacement linker sequence 
had no effect on SNAP25 S-acylation by 
zDHHC17 (Figure 5B). Accordingly, we 
found that the GS mutant could co-IP 
zDHHC17 as efficiently as WT SNAP25, 
showing that the interaction between SNAP25 
and zDHHC17 is not dependent on the exact 
sequence of the mini-linker region (Figure 
5C). Figure 5D confirms that C16:0-azide 
groups are linked to cysteines via thioester 
bonds on the GS linker mutant as the click 
signal disappeared after treatment of the 
samples with hydroxylamine.  
Although the replacement linker had no effect 
on S-acylation by zDHHC17, it is possible that 
it could impact the localisation of SNAP25. To 
examine the effect on localisation, we 
performed experiments in PC12 cells. EGFP-
SNAP25 is efficiently S-acylated by 
endogenous zDHHC enzymes in this cell line, 
and mutation of the zDABM blocks S-
acylation, demonstrating dependence on 
endogenous zDHHC17 (23,29). In addition, 
SNAP25 is endogenously-expressed in PC12 
cells and over-expressed EGFP-SNAP25 
localises correctly to the plasma membrane 
and endosome/trans Golgi network 
compartment in these cells (30). Cellular 
fractionation showed that the GS Linker 
mutant associated with membranes to the same 
extent as wild-type SNAP25 in PC12 cells 
(Figure 6A). Moreover, confocal imaging and 
analysis also revealed that the mini-linker 
mutations had no effect on the intracellular 
localisation: both EGFP-tagged SNAP25 WT 
and GS Linker mutant co-localised to the same 
extent with a mcherry-tagged SNAP25 protein 
when co-expressed in PC12 cells (Figure 6B).   
Altogether these results show that the exact 
amino acid sequence of the mini-linker region 
of SNAP25 is not important for its S-acylation 
by zDHHC17 or subsequent targeting to the 
plasma membrane and endosomal 
compartments. 
Increasing the affinity of the zDABM for 
zDHHC17 leads to reduced S-acylation 
efficiency 
Lemonidis et al (21) have previously defined 
the potentially optimal zDABM amino acid 
sequence for the binding of substrates to the 
zDHHC17 ANK domain. A ‘favourable 
peptide’ sequence was synthesized based on 
the sequence rules defined for the SNAP25 
zDABM and found to interact more strongly 
than a WT SNAP25 zDABM peptide with the 
soluble ANK domain of zDHHC17 (21). We 
therefore modified the zDABM of SNAP25 to 
include most of the amino acids of the 
‘favourable peptide’ (mutant referred to herein 
as ‘LFP’ for Lemonidis Favourable Peptide) 
(Figure 7A). We found that these amino acid 
substitutions indeed led to a marked increase 
in co-IP of HA-zDHHC17 (Figure 7B), 
confirming that the strength of interaction was 
increased. When S-acylation of this high 
affinity mutant was examined, it was found 
that there was no effect on S-acylation 
mediated by zDHHC7, whereas the LFP 
substitutions significantly decreased the S-
acylation of SNAP25 by zDHHC17 (Figure 
7C), showing that a higher affinity interaction 
between the enzyme and substrate was actually 
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detrimental for S-acylation of SNAP25 in 
cells. Hydroxylamine treatment of the samples 
induced a disappearance of the click signal 
(Figure 7D), showing that C16:0-azide is 
bound to the LFP mutant through thioester 
bonds, as expected.   
The insertion and deletion mutants ∆(101-
108) and (AP)6 show a reduced membrane 
association when expressed in PC12 cells  
Our previous work has shown that EGFP-
SNAP25 is efficiently S-acylated in PC12 
cells, most likely by endogenous zDHHC17. 
Thus, we examined the membrane targeting of 
SNAP25 WT or the ∆(101-108), (AP)6 or LFP 
mutants in these cells in the absence of 
zDHHC enzyme co-expression. Figure 8A 
shows that both the ∆(101-108) and (AP)6 
mutants had a significantly increased presence 
in purified cytosolic fractions and a decreased 
association with membrane fractions compared 
to WT SNAP25 when expressed in PC12 cells. 
These results are consistent with the reduced 
S-acylation observed for these mutants when 
co-expressed with zDHHC17 in HEK293T 
cells. In contrast, the LFP mutant associated 
with membranes to the same extent as the WT 
protein when expressed in PC12 cells. This 
result suggests that although a higher affinity 
for zDHHC17 interferes with the S-acylation 
process in HEK293T cells, this does not have 
a major impact on steady state SNAP25 
membrane association in PC12 cells. The 
cytosol and membrane fractions were also 
probed with antibodies against Hsp90 and 
syntaxin, a soluble and transmembrane 
protein, respectively. Finally, we examined the 
intracellular localisation of the ∆(101-108) 
mutant, which is the most affected in its 
membrane association, by confocal 
microscopy (Figure 8B). This confirmed the 
increased cytosolic localisation of this mutant 
compared to WT. Interestingly, we also 
detected an accumulation of this mutant in the 
Golgi region of the cells (lower panel), 
consistent with the idea that this mutant retains 
an underlying membrane affinity and can 
interact with zDHHC17 (which is Golgi 
localised) but has a defect in subsequent S-
acylation.  
 
DISCUSSION 
Identification of the substrate networks of 
individual zDHHC enzymes is a major 
requirement for progress of the S-acylation 
field. Experiments to determine these substrate 
networks (e.g. by zDHHC depletion and 
quantitative proteomics) will be complicated 
by the observation that zDHHC enzymes can 
have overlapping substrate selectivity (1). 
SNAP25, the focus of the current study, 
interacts with and is S-acylated by zDHHC17 
(6,17,19,21,23,29). However, co-expression 
experiments have revealed that this protein can 
also be modified by zDHHC2, zDHHC3, 
zDHHC7 and zDHHC15 (6,22). Indeed, 
zDHHC3 and zDHHC7 S-acylate SNAP25 to 
a greater extent than zDHHC17, despite 
zDHHC3/7 displaying no detectable 
interaction with SNAP25 (17). Furthermore, 
zDHHC3/7 can modify a diverse set of 
substrates that have no obvious sequence or 
structural similarities. Based on this, we 
believe that zDHHC3/7 are “high activity/low 
selectivity” enzymes that modify accessible 
and reactive cysteines on proteins that co-
localise at the Golgi (e.g. during trafficking of 
newly-synthesised proteins), in the absence of 
any specific enzyme-substrate recognition. In 
contrast, zDHHC17 is a “low activity/high 
selectivity” enzyme that depends upon specific 
interactions with its substrate proteins to 
mediate S-acylation. This idea is supported by 
several observations, including: (i) removal of 
the substrate-binding ANK domain prevents S-
acylation by zDHHC17 (17) and (ii) mutation 
of the zDABM motif of SNAP25 prevents S-
acylation by zDHHC17 (19,21-23). Indeed, it 
is interesting to note that although zDHHC3 
and zDHHC7 robustly S-acylate SNAP25 in 
co-expression experiments, mutation of the 
zDABM in SNAP25 leads to a loss of 
membrane binding (and thus presumably S-
acylation) in PC12 cells (22), demonstrating 
the importance of zDHHC17 for SNAP25 S-
acylation in this cell type at least. 
The current study sought to determine features 
of SNAP25 that are important for the coupling 
of binding to zDHHC17 with subsequent S-
acylation. This question is important as we 
showed that zDHHC17 interacts with zDABM 
sequences from a diverse set of proteins and 
that several of these binders are not known to 
be S-acylated (21). Thus, we were interested in 
the features of SNAP25 that allow it to be a 
zDHHC17 S-acylation substrate. The results of 
the study showed that there is a minimum 
separation length required between the 
cysteine-rich domain and zDABM for S-
acylation by zDHHC17. These two regions of 
SNAP25 are separated by 19 amino acids 
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(residues 93-111); as this part of SNAP25 is 
thought to be disordered (27), an extended 
peptide sequence of this length would be in the 
region of 7.6 nm (assuming 0.4 nm per amino 
acid (31)). Removal of four amino acids was 
tolerated, whereas removal of five or more 
amino acids from this linker region reduced S-
acylation, suggesting a minimal required 
separation in the order of 6 nm between 
zDABM and cysteines for efficient S-
acylation. Although the structure of full-length 
zDHHC17 has not been reported, these 
approximate calculations of the displacement 
of the ANK domain and DHHC domain of 
zDHHC17 can be tested when structural 
information is available. By using mPEG-
Click analysis of C85L and C92L mutants of 
(101-105) and (101-106), it was found that 
the C85L mutation had a greater effect than 
the C92L mutation in the context of the 
deletion mutants, whereas there was no 
obvious difference between these mutations in 
full-length SNAP25. This supports that idea 
that as the mini-linker is shortened, cysteines 
closer to the zDABM (i.e. C92) become less 
accessible for S-acylation before cysteines 
further from the zDABM (i.e. C85), thus why 
Cys-85 mutation has a greater effect than Cys-
92 mutation on S-acylation of the linker 
deletion mutants. Additionally, our previous 
work suggested that the hydrophobic cysteine-
rich domain of SNAP25 mediates initial 
transient association of SNAP25 with Golgi 
membranes, allowing the protein to interact 
with its target zDHHC enzyme (zDHHC17) 
(23). Thus, we predicted that the ∆(101-108) 
mutant that has a defect in S-acylation but not 
in its interaction with zDHHC17 might show 
some accumulation at Golgi membranes when 
expressed in PC12 cells. Confocal analysis 
indeed showed accumulation of this protein in 
a Golgi-like region of the cell. 
The mPEG-Click technique newly described 
here was used to generate additional data to 
the ones obtained with the widely used dye-
click technique. Indeed, mPEG-Click reveals 
the number of S-acylated cysteines and also 
differentiates between mutations affecting the 
overall S-acylation of a protein and mutations 
affecting the S-acylation of specific cysteines 
within a protein. Coupled with pulse chase and 
time course analyses, mPEG-Click could be 
used to study the dynamics and progress of 
cysteine S-acylation / deacylation within 
multiply S-acylated proteins. Since the S-
acylation profile of a protein is simply 
revealed with antibodies against this protein, 
overexpression of the protein of interest is not 
strictly necessary as long as the antibody is 
sensitive enough to detect the endogenous 
protein, and that the epitopes are not masked 
by the addition of the mPEG group to the S-
acylated cysteines. In our opinion, mPEG-
Click might provide an easy and 
straightforward mean to investigate the S-
acylation status of any endogenous or 
overexpressed protein in various cell types. 
Previous work used a similar band-shift 
brought about by ligation of azido-TAMRA-
PEG-Biotin to alkynyl cholesterol analogues 
to study cholesterylation of Sonic Hedgehog 
(32). 
This work describes the first use of mPEG-
Click methodology to study the dynamics of 
protein S-acylation. However, another PEG-
based assay, variably referred to as PEG-
switch (33), acyl-PEG exchange (APE) (34) or 
acyl-PEGyl exchange gel shift (APEGS) (7) is 
commonly used in the S-acylation field. This 
methodology is different from mPEG-Click as 
it involves removal of unlabelled acyl chains 
with hydroxylamine followed by labelling of 
the thus freed cysteines by a cysteine-reactive 
reagent such as PEG-maleimide. mPEG-Click 
and acyl-PEG switch both have distinct 
advantages, for example acyl-PEG switch is 
well suited to study the extent of S-acylation 
on endogenous proteins in cell and tissue 
extracts, whereas mPEG-Click has wider 
scope for the analysis of S-acylation dynamics 
in living cells.  
In contrast to mutations that shortened the 
mini-linker region, addition of a 10-amino acid 
flexible glycine-serine linker had no major 
effect on S-acylation. This suggests that 
whereas there is a strict requirement for a 
minimal separation distance between zDABM 
and S-acylated cysteines, there is more 
flexibility around the maximal length, 
presumably because a longer disordered and 
flexible linker can adopt a spatial orientation 
that can simultaneously dock the zDABM and 
cysteines of a substrate into the ANK domain 
and DHHC domain of zDHHC17, 
respectively. In contrast, the insertion of rigid 
inflexible alanine-proline sequences into the 
mini-linker region of SNAP25 perturbed S-
acylation by zDHHC17 presumably by 
limiting spatial flexibility of the linker region 
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and hence the spatial optimisation of zDABM 
and cysteine-rich domain of this protein. 
Interestingly, analysis of the GS Linker mutant 
that had a complete replacement of the 19-
amino acid linker with a similar length GS 
linker suggested that the mini-linker sequence 
is not important for either S-acylation or 
intracellular targeting of SNAP25. It was 
notable however that this GS Linker mutant 
was less efficiently S-acylated by zDHHC7. 
Our previous work suggested that the 
hydrophobic cysteine-rich domain of SNAP25 
(residues 85-92) plays an important role in 
initial membrane interaction of SNAP25 with 
Golgi membranes prior to S-acylation (23). In 
contrast, a study by the Lang group suggested 
a role for positively-charged amino acids in 
the (large) linker domain in mediating this 
initial membrane interaction (35). However, it 
is worthwhile further reflecting on the 
proposed role of positively-charged amino 
acids in initial membrane interaction of 
SNAP25 (35). The results of the current study 
clearly show that lysine residues in the mini-
linker are dispensable for S-acylation mediated 
by zDHHC17 and for membrane association 
and intracellular targeting in PC12 cells. 
Furthermore, any positively-charged residues 
upstream of the cysteine-rich domain are also 
dispensable as the minimal S-acylation and 
membrane targeting domain in SNAP25b is 
amino acids 85-120 (36). Thus, it is likely that 
any role played by positively-charged amino 
acids of SNAP25 is secondary to the 
prominent role of the hydrophobic cysteine-
rich domain in initial membrane targeting of 
this protein (23). Indeed, the importance of the 
non-acylated cysteine-rich domain in 
membrane interactions of SNAP25 was further 
shown by a recent study (37). The effect of 
mini-linker replacement on S-acylation by 
zDHHC7 may reflect the idea that this enzyme 
does not interact with SNAP25 directly (17) 
but rather mediates “stochastic” S-acylation of 
this protein when it is present at the 
membrane. Thus, a slight loss in membrane 
affinity caused by mini-linker replacement 
could lead to the reduced S-acylation seen 
with zDHHC7, whereas a slight reduction in 
membrane affinity may still be sufficient to 
promote efficient zDHHC17-SNAP25 
interaction and subsequent S-acylation. 
The affinity of the zDABM of SNAP25 for the 
ANK domain of zDHHC17 was calculated to 
be ~ 11 M, although full-length SNAP25 had 
a higher affinity (20). This interaction affinity 
is clearly sufficient to allow robust isolation of 
the protein complex by co-IP. However, we 
were interested in whether enhancing the 
affinity of interaction would lead to higher 
levels of S-acylation. To test this idea, we used 
data from a previous study by our group (21) 
to generate a SNAP25 mutant, which was 
predicted to have an increased affinity for the 
ANK domain of zDHHC17. In support of this 
idea, the mutant captured higher levels of 
zDHHC17 by co-IP. Despite this increased 
binding capacity, the LFP high affinity mutant 
displayed a reduced S-acylation by zDHHC17 
when expressed in HEK293T cells, suggesting 
that tight binding between zDHHC enzymes 
and other proteins is not always conducive to 
efficient S-acylation; perhaps tighter binding 
limits the catalytic turnover of the enzyme. It 
was interesting to note that although the LFP 
mutant displayed reduced S-acylation by 
zDHHC17 (but not zDHHC7) in HEK293T 
cells, there was no significant loss of 
membrane binding of this mutant in PC12 
cells. We believe that this reflects the fact that 
membrane binding of the LFP mutant in PC12 
cells was measured 48 hours after transfection 
and reflects the steady-state distribution of the 
protein. In contrast, S-acylation assays in 
HEK293T cells are performed over 4 hours 
and are therefore better suited to detect 
changes in the overall kinetics of S-acylation. 
In theory, the reduced S-acylation signal of 
specific SNAP25 linker mutants in click 
chemistry experiments could reflect either a 
defect in S-acylation or an enhanced rate of 
deacylation. However, in all experiments, 
where zDHHC17-mediated S-acylation was 
reduced, we showed that there was no effect 
on S-acylation levels of the corresponding 
mutants co-expressed with zDHHC7. This 
clearly implies that the linker mutants have a 
specific defect in S-acylation mediated by 
zDHHC17 rather than any changed in 
deacylation rate. 
This study demonstrates that the length and 
flexible character of the mini-linker region of 
SNAP25 are important features for efficient S-
acylation. In contrast, the sequence of the 
mini-linker is less important for efficient S-
acylation as long as it confers structural 
flexibility. In follow-up work it would be 
interesting to examine the interaction between 
zDHHC17 and SNAP25 using purified 
proteins. This would allow a more detailed 
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analysis of factors such as Km and Kcat and 
how these are affected by changes to the linker 
region of SNAP25. This analyses would allow 
a more refined understanding of the 
enzymology of zDHHC17 to emerge. Future 
work will also determine if the sequence of the 
mini-linker is important for the function of 
SNAP25 in fusion pore dynamics and 
exocytosis (38). 
 
EXPERIMENTAL PROCEDURES 
Antibodies 
Mouse GFP antibody (Clontech, clone JL8, 
used at 1:4,000) was obtained from Takara 
(Saint-Germain-en-Laye, France). Rat HA 
antibody (Roche, clone 3F10, used at 1:1,000) 
was from Sigma (Poole, UK). Rabbit HSP90 
antibody (C45G5, used at 1:1,000) was from 
Abcam (Cambridge, UK). Mouse anti 
Syntaxin antibody (HPC-1 S0664, used at 
1:1,000) was from Sigma (UK). IR dye 
conjugated secondary antibodies (used at 
1:20,000 dilution) were purchased from Li-
COR Biosciences (Cambridge, UK).  
Plasmid DNA 
cDNA encoding human zDHHC7 and 
zDHHC17, and the (AP)6 and GS Linker 
SNAP25b mutants were synthesized by 
Thermo Fisher Scientific (Loughborough, 
UK). The cDNA encoding zDHHC7 and 
zDHHC17 were sub-cloned into pEF-BOS HA 
(6), whereas the SNAP25b constructs were 
sub-cloned in pEGFP-C2 (23). Wild-type rat 
SNAP25b (in pEGFP-C2), SNAP25 mutants 
with deletions of the linker region and 
mcherry-SNAP25 were previously described 
(23,30). All other mutants described in this 
report were generated by site-directed 
mutagenesis using oligonucleotide primers 
synthesised by Sigma (Poole, UK). The 
validity of all constructs was confirmed by 
sequencing (Dundee DNA sequencing Service, 
UK). 
Cells 
HEK293T cells (CRL-3216, ATCC) were 
grown in DMEM media (Thermo Fisher 
Scientific) supplemented with 10% foetal 
bovine serum. PC12 cells (CRL-1721, ATCC) 
were grown in Advanced RPMI 1640 media 
(Thermo Fisher Scientific) containing 10% 
horse serum, 5% foetal bovine serum and 1% 
glutamine. All cells were grown at 37oC in a 
humidified atmosphere containing 5% CO2. 
Cell transfection 
For substrate S-acylation and 
immunoprecipitation assays, HEK293T were 
plated on poly-D-lysine coated 24-well plates 
(Corning BioCoat, VWR, UK) and transfected 
with 0.33 μg of EGFP-SNAP25 plasmid and 
0.66 μg of pEF-BOS HA plasmid (either 
empty as a control or encoding the zDHHC 
enzymes). 2 μl of polyethylene imine (PEI) (1 
mg / ml stock) (linear PEI mw 25,000, 
#43896, Alpha Aesar, UK) was added to the 
DNA mix, incubated for 20 min and then 
added to the cells, which were analysed the 
following day. 
For cell fractionation and immunofluorescence 
analyses, PC12 cells were plated on poly-D-
lysine coated 24-well plates or on 12 mm BD 
poly-D-lysine coated coverslips (Thermo 
Fisher Scientific, UK), respectively. Cells 
were transfected using Lipofectamine 2000 
(Invitrogen, UK) with a ratio of 2 μl of 
Lipofectamine / μg of DNA. For fractionation 
experiments, 1 μg of EGFP SNAP25 WT or 
mutants was transfected whereas 0.2 μg of 
EGFP SNAP25b WT or mutants was 
transfected together with 0.2 μg of mCHERRY 
SNAP25b WT for immunofluorescence 
analysis. Cells were incubated with the 
transfection mixture for approximately 48 h 
before analysis. 
Cell Labelling with fatty acids 
HEK293T cells in 24 well plates were 
incubated with 100 μM of either palmitic acid 
(P0500, Sigma, UK) or C16:0-azide (16) in 
350 μl of serum free DMEM supplemented 
with 1 mg/ml defatted BSA (A7030, Sigma, 
UK) for 4 h at 37°C.  
Detection of palmitate labelled probes in S-
acylated proteins 
Cells were washed once with PBS then lysed 
on ice in 100 μl of 50 mM Tris pH 8.0 
containing 0.5% SDS and protease inhibitors 
(P8340, Sigma, UK). Conjugation of 
IR800CW Alkyne Dye or mPEG5K Alkyne to 
C16:0-azide was carried out for 1 h at room 
temperature with end-over-end rotation by 
adding an equal volume (100 μl) of freshly 
prepared click chemistry reaction mixture 
containing the following: 5 μM IRDye 800CW 
Alkyne (929-60002, Li-COR, UK) or 200 μM 
mPEG5k-Alkyne (JKA3177, Sigma, UK), 4 
mM CuSO4 (451657, Sigma, UK), 400 μM 
Tris[(1-benzyl-1H-1,2,3-triazol-4-
yl)methyl]amine (678937, Sigma, UK) and 8 
mM ascorbic acid (A15613, Alpha Aesar, UK)  
in dH2O. 67 μl of 4x SDS sample buffer 
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containing 100 mM DTT was then added to 
the 200 μl sample. Protein samples were 
incubated at 95°C for 5 min and 19 μl was 
resolved by SDS-PAGE and transferred to 
nitrocellulose for immunoblotting analysis. 
Immunoblots were quantified with the 
ImageStudio software from Li-Cor. Graphs 
and statistical analysis was performed using 
GraphPad software. 
Quantification and determination of the 
efficiency of S-acylation 
S-acylation was calculated as the ratio between 
Click signal (IR800) and GFP signal (IR680). 
This ratio was then normalised to control 
conditions on the same membrane. For Alkyne 
mPEG treated samples, the efficiency of S-
acylation was calculated as the ratio between 
the sum of GFP signals corresponding to 1,2,3 
and 4 modified cysteines and the sum of all the 
signals (i.e. sum of 0,1,2,3 and 4 modified 
cysteines). The value for cells incubated with 
unlabelled palmitate was then subtracted from 
the values of similarly transfected cells 
incubated with C16:0-azide. The efficiency of 
S-acylation was then normalised to control 
conditions. 
Chemical deacylation 
HEK293T cells were transfected, and labelled 
by click chemistry (IRDye 800 CW) as 
described above. Proteins were precipitated by 
the addition of 3 volumes of ice cold acetone 
and incubation at -20°C for 30 minutes. Pellets 
resulting from a 10-minute centrifugation at 
16,000 g (4°C) were then washed 3 times with 
ice cold 70% acetone, air dried for 10 minutes 
and resuspended in 100 mM Hepes pH 7.5, 1 
mM EDTA, 1% SDS. 20 μl aliquots were then 
incubated with an equal volume of 2M Tris 
(pH 7.5) or 2M Hydroxylamine (pH 7.5) for 1 
hour at room temperature. Samples were 
resolved and analysed by SDS PAGE. 
Immunoprecipitation 
Cells were co-transfected with plasmids 
encoding EGFP-SNAP25 constructs together 
with a HA-tagged zDHHC17 construct on 24 
well plates. Three identical wells were 
gathered for each immunoprecipitation. Cells 
were washed, lysed in 200 μl of PBS, 0.5% 
Triton X-100 (T8787, Sigma, UK) 
supplemented with protease inhibitors for 30 
min on ice and clarified by centrifugation at 
16,000 g for 10 min at 4°C. The supernatants 
were then adjusted to 0.2% Triton X-100 by 
the addition of 300 μl of cold PBS. Whereas 
50 l of lysate was kept as the input fraction, 
450 μl of lysate was added to 8 μl (slurry 
volume) of washed GFP-Trap agarose beads 
(GTA-20, Chromotek GmbH, Germany). The 
tubes were incubated on an end-over-end 
rotator at 4°C for 1 h. The beads were then 
washed twice with PBS and eluted with 50 μl 
of 2x SDS PAGE sample buffer containing 50 
mM DTT with a 5 min incubation at 95°C. 
Fractionation of PC12 cells 
Transfected PC12 cells were detached from 
the wells in 500 μl PBS and transferred to 
Eppendorf tubes. Cell fractionation was 
performed as described by S. Baghirova et al 
(39). Briefly, cells were washed in PBS, 
resuspended in 150 μl of Buffer A (150 mM 
NaCl, 50 mM HEPES pH 7.4, 1M Hexylene 
glycol (112100, Sigma, UK), 25 μg/ml 
digitonin (D141, Sigma, UK)) supplemented 
with protease inhibitors and rotated end-over-
end at 4°C for 10 min. The supernatant of a 
2,000 g, 10 min centrifugation at 4°C was 
collected as the ‘Cytosolic Fraction’. The 
pellet was washed briefly in Buffer A before 
being resuspended by vortexing in 150 μl of 
Buffer B (150 mM NaCl, 50 mM pH 7.4, 1M 
Hexylene glycol, 1% v/v Igepal (CA-630, 
Sigma, UK) supplemented with protease 
inhibitors. After 30 min incubation on ice, the 
lysates were centrifuged at 7,000 g for 10 min 
at 4°C; the supernatant was collected as the 
‘Membrane Fraction’. Both Cytosolic and 
Membrane fractions were supplemented with 
4x SDS PAGE loading buffer containing 100 
mM DTT and incubated at 95°C for 5 min. 
Proteins were resolved by loading an equal 
volume of each fraction by SDS-PAGE and 
analysis by immunoblotting. The effectiveness 
of the membrane/cytosol fractionation was 
assessed by probing with antibodies against 
Syntaxin and Hsp90.   
Immunofluorescence, confocal microscopy 
and image analysis 
Transfected cells were washed once with PBS 
and fixed in 4% formaldehyde for 30 min. The 
cells were then washed again in PBS and 
mounted on glass slides in Mowiol. All 
microscopy analysis was performed on a Leica 
SP8 confocal microscope; image stacks were 
acquired with the Lightning function. A single 
slice was chosen as a representative image. 
Image quantification was performed with the 
Fiji software. The Co-localisation Threshold 
tool was used to calculate the Pearson’s co-
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localisation coefficient r. Statistical analysis was performed with the GraphPad software. 
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FOOTNOTES 
The abbreviations used are: SNAP25, synaptosomal-associated protein of 25kDa; ANK, ankyrin 
repeat; zDABM, zDHHC ANK binding motif; HEK293T, human embryonic kidney 293T; ER, 
endoplasmic reticulum; SLiM, short linear motif; LFP, Lemonidis favourable peptide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE LEGENDS 
Figure 1. Shortening the linker region of SNAP25 decreases S-acylation by zDHHC17 without 
impairing interaction with the enzyme. A. Top panel: schematic of the deletions introduced in the 
linker region of EGFP-SNAP25. Middle and Bottom Panels. HEK293T cells were transfected with 
either EGFP SNAP25b WT (GFP S25b WT) or the various deletion mutants (∆(101-104), ∆(101-
105), ∆(101-106), ∆(101-107), ∆(101-108)) together with either a plasmid encoding HA zDHHC17 (+ 
HA zD17) or a control pEF-BOS HA plasmid (- HA zD17). Cells were then incubated with 100 μM 
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C16:0-azide and proteins incorporating the azide fatty acid were labelled by click chemistry using an 
alkyne-infrared 800 dye (Alk-IR800). Proteins were resolved by SDS-PAGE and transferred to 
nitrocellulose membranes. Representative images are shown (Middle panel): click chemistry signal 
(Top, Alk IR800), GFP (Middle, IR680) and HA (Bottom, IR680) immunoblots. Graph (Bottom panel) 
shows mean +/- SEM of normalised S-acylation with HA zDHHC17; filled circles represent 
individual samples (n=3 different cell samples for each condition). Statistical analysis (ANOVA) 
showed no significant difference between the zDHHC17 mediated S-acylation of WT vs ∆(101-104) 
whereas there was a significant difference for WT vs ∆(101-105) (**, p<0.01), ∆(101-106), ∆(101-
107) and ∆(101-108) (***, p<0.001). B. HEK293T cells were transfected with either EGFP SNAP25b 
WT (GFP S25b WT) or the ∆(101-108) deletion mutant together with HA zDHHC7 (+ HA zD7) or a 
control pEF-BOS HA plasmid (- HA zD7). Cells were then treated as in A. Representative images are 
shown on the left panel: click chemistry signal (Top, IR 800), GFP (Middle, IR 680), and HA (Bottom, 
IR680) immunoblots. Graph on the right panel shows mean +/- SEM of normalised S-acylation with 
HA zDHHC7; filled circles represent individual samples (n=3 different cell samples for each 
condition). Statistical analysis (Student’s t-test) showed no significant difference between the S-
acylation of WT vs ∆(101-108) by zDHHC7. C. HEK293T cells were transfected with either EGFP 
SNAP25b WT (GFP S25b WT), the ∆(101-108) deletion mutant (GFP S25b ∆(101-108)), or 
additional control plasmids (GFP SNAP25b P117G or GFP) together with HA zDHHC17 (+ HA 
zD17). Lysates (right panel, Input) were immunoprecipitated (IP) with an anti GFP antibody (left 
panel), resolved by SDS-PAGE and transferred to nitrocellulose membranes. Membranes were probed 
with anti GFP (Top) or anti HA (Bottom) antibodies. The ratio between the HA signal and the GFP 
signal was quantified for the immunoprecipitated samples and is indicated at the bottom. D. 
HEK293T cells were transfected with either EGFP SNAP25b WT (GFP S25b) or the ∆(101-108) 
deletion mutant (GFP S25b ∆(101-108)) together with a plasmid encoding HA zDHHC17 (+HA 
zD17) and were treated as in A. Clicked chemistry labelled samples were then concentrated by 
acetone precipitation, aliquoted and incubated with an equal volume of either 2M hydroxylamine (+ 
NH2OH) or 2M Tris (- NH2OH) for 1h at room temperature. They were then resolved and analysed by 
SDS PAGE. The top panel shows the click chemistry signal (Alk-IR800) whereas the bottom panel 
shows the anti GFP immunoblot (IR680). Position of molecular weight markers (in kDa) are shown 
on the right or left side of all immunoblots 
Figure 2. The mPEG-Click technique enables detection of the number of S-acylated cysteines on 
SNAP25. A. HEK293T cells were transfected with EGFP SNAP25b WT (GFP S25b WT) together 
with a plasmid encoding HA zDHHC7 (+ HA zD7) or a control pEF-BOS HA plasmid (- HA zD7). 
Cells were then incubated with 100 μM C16:0-azide (+ Az C16:0) or palmitic acid (- Az C16:0). 
Proteins incorporating C16:0-azide were labelled by click chemistry using increasing concentrations 
of alkyne-mPEG 5K (0 to 125 μM). Proteins were resolved by SDS-PAGE, transferred to 
nitrocellulose membranes and probed with a GFP antibody. Molecular weight markers are shown on 
the left whereas numbers on the right relate to the number of modified cysteines detected. B. 
HEK293T cells were transfected with either EGFP SNAP25b WT (WT) or an EGFP SNAP25b 
mutant where all cysteines had been mutated to leucines (4CL) together with a plasmid encoding HA 
zDHHC7 (+ HA zD7). Cells were then incubated with 100 μM C16:0-azide (+ Az C16:0) or palmitic 
acid (- Az C16:0). Proteins incorporating C16:0-azide were labelled by click chemistry using 100 μM 
alkyne-mPEG 5K. Isolated proteins were resolved by SDS-PAGE, transferred to nitrocellulose 
membranes and probed with a GFP antibody. C. HEK293T cells were transfected with EGFP 
SNAP25b WT (GFP S25b WT) together with a plasmid encoding either HA zDHHC7 (+ HA zD7), or 
an inactive mutant of zDHHC7 where the catalytic cysteine had been mutated into an alanine (HA 
zD7 C160A) or control pEF-BOS HA plasmid (pEF). Cells were processed as described for panel B. 
D. HEK293T cells were transfected with EGFP SNAP25b WT (WT) or single cysteine mutants 
(C85L, C88L, C90L and C92L) together with a plasmid encoding HA zDHHC7 (+ HA zD7). Cells 
were then labelled and analysed as in panel B. E. HEK293T cells were transfected with EGFP 
SNAP25b WT or double cysteine mutants (C85/88L, C85/90L, C85/92L, C88/90L C88/92L and 
C90/92L) together with a plasmid encoding HA zDHHC7 (+ HA zD7). Cells were then labelled and 
analysed as in panel B. F. HEK293T cells were transfected with EGFP SNAP25b WT together with a 
plasmid encoding HA zDHHC7 (HA zD7), HA zDHHC17 (HA zD17) or a control plasmid pEF-BOS 
HA (pEF). Cells were then labelled and analysed as in panel B. 
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Figure 3. mPEG-Click analysis of SNAP25 linker deletion mutants. A. HEK293T cells were 
transfected with either EGFP SNAP25b WT (GFP S25b WT) or the various deletion mutants (∆(101-
104), ∆(101-105), ∆(101-106), ∆(101-107), ∆(101-108)) together with a plasmid encoding either HA 
zDHHC7 (+ HA zD7) or HA zDHHC17 (+ HA zD17). Cells were then incubated with C16:0 azide 
and proteins incorporating the fatty acid azide were labelled by click chemistry using alkyne-mPEG 
5K. Proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes and probed 
with a GFP antibody. Position of molecular weight markers are shown on the left whereas numbers on 
the right relate to the number of modified cysteines in SNAP25. B. Schematic of the mutants of EGFP 
SNAP25b used in the analysis. Cysteine-to-Leucine mutations (underlined) were introduced at 
position 85 (C85L) or 92(C92L) of EGFP SNAP25b WT (WT S25b) or the deletion mutants EGFP 
SNAP25b ∆(101-105) and ∆(101-106). B (continued). HEK293T cells were transfected with the 
various constructs described above together with a plasmid encoding either HA zDHHC7 (HA zD7) 
or HA zDHHC17 (HA zD17). Cells were then incubated with C16:0 azide (+ Az C16:0) or palmitic 
acid (- Az C16:0). Proteins incorporating the fatty acid azide were labelled by click chemistry using 
alkyne-mPEG 5K. Isolated proteins were resolved by SDS-PAGE, transferred to nitrocellulose 
membranes and probed with a GFP antibody. Position of molecular weight markers are shown on the 
left of the first immunoblot whereas numbers on the right relate to the number of mPEG-modified 
cysteines. Graphs show mean +/- SEM of normalised S-acylation of WT and mutant SNAP25 
proteins with HA zDHHC7 or HA zDHHC17; filled circles represent individual samples (n=6 or 9 
different cell samples for each condition). Statistical analysis (ANOVA followed by a Tukey’s post 
hoc test) was performed to reveal significant differences within subgroups of conditions (WT vs C85L 
or C92L – indicated directly above the bars - or C85L vs C92L - indicated on the graphs above a plain 
line) (*, p<0.05; **, p<0.01; ***, p<0.001). 
Figure 4. Differential effects of flexible versus rigid sequences inserted into the linker domain of 
SNAP25. A. Top panel. Schematic showing the introduction of a duplicated flexible sequence 
composed of 4 glycines and 1 serine (G4S)2 at position 104 of EGFP SNAP25b. Middle and bottom 
panels. HEK293T cells were transfected with either EGFP SNAP25b WT (GFP S25b WT) or the 
(G4S)2 insertion mutant together with a plasmid encoding either HA zDHHC7 (+ HA zD7), HA 
zDHHC17 (+ HA zD17) or a control pEF-BOS HA plasmid (- HA zD7, - HA zD17). Cells were then 
incubated with C16:0 azide and proteins incorporating the fatty acid azide were labelled by click 
chemistry using an alkyne-800 infrared dye (Alk-IR800). Isolated proteins were resolved by SDS-
PAGE and transferred to nitrocellulose membranes. Representative images are shown (Middle panel): 
click chemistry signal (Top, Alk IR800), GFP (Middle, IR680) and HA (Bottom, IR680) immunoblots. 
Graphs (Bottom panel) show mean +/- SEM of normalised S-acylation with HA zDHHC7 or HA 
zDHHC17; filled circles represent individual samples (n=6 different cell samples for each condition). 
Statistical analysis (Student’s t-test) showed no significant difference between the S-acylation of WT 
vs (G4S)2 by zDHHC7 whereas there was a significant difference of the S-acylation of WT vs (G4S)2 
by zDHHC17 (*, p<0.05). B. Schematic showing the introduction of (AP)2, (AP)4 or (AP)6 at position 
104 of EGFP SNAP25b. B continued.  HEK293T cells were transfected with either EGFP SNAP25b 
WT (GFP S25b WT) or the (AP) insertion mutants ((AP)2, (AP)4 and (AP)6) together with a plasmid 
encoding HA zDHHC7 (+ HA zD7), HA zDHHC17 (+ HA zD17) or a control pEF-BOS HA plasmid 
(- HA zD7, - HA zD17). Cells were then incubated with C16:0-azide and proteins incorporating the 
fatty acid azide were labelled by click chemistry using an alkyne-800 infrared dye. Proteins were 
resolved by SDS-PAGE and transferred to nitrocellulose membranes. Representative images are 
shown (Left panel): click chemistry signal (Top, IR800), GFP (Middle, IR680) and HA (Bottom, 
IR680) immunoblots. Graphs (Right panel) show mean +/- SEM of normalised S-acylation with HA 
zDHHC7 or HA zDHHC17; filled circles represent individual samples (n=6 different cell samples for 
each condition). Statistical analysis (ANOVA) showed no significant difference between the S-
acylation of WT versus any of the (AP) insertion mutants
 
by zDHHC7 whereas there was a significant 
difference of the S-acylation of WT versus (AP)4 and (AP)6 by zDHHC17 (***, p<0.001). C. 
HEK293T cells were transfected with EGFP SNAP25b (AP)6 (GFP S25b (AP)6) together with a 
plasmid encoding HA zDHHC17 (+ HA zD17). Cells were then metabolically labelled with C16:0 
azide followed by click chemistry using an alkyne-800 infrared dye (Alk-IR800). Cell samples were 
then concentrated by acetone precipitation, aliquoted and incubated with an equal volume of either 
2M hydroxylamine (+ NH2OH) or 2M Tris (- NH2OH) for 1h at room temperature. They were then 
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resolved and analysed by SDS PAGE. The left panel shows the click chemistry signal (Alk-IR800) 
whereas the right panel shows the anti GFP immunoblot (IR680). Position of molecular weight 
markers (in kDa) are shown on the right or left side of all immunoblots. 
 
Figure 5. Replacing the linker region of SNAP25 with a flexible glycine-serine linker of the same 
length has no effect on SNAP25 S-acylation by zDHHC17. A. Amino acids (underlined) between 
the S-acylation domain and the zDABM of EGFP SNAP25b (WT S25b) were replaced by several 
copies of the flexible GGGGS sequence to create the GS Linker mutant. B. HEK293T cells were 
transfected with either EGFP SNAP25b WT (GFP S25b WT) or the GS Linker mutant together with 
either a plasmid encoding either HA zDHHC7 (+ HA zD7), HA zDHHC17 (+ HA zD17) or a control 
pEF-BOS HA plasmid (- HA zD7, - HA zD17). Cells were then incubated with C16:0-azide and 
proteins incorporating the fatty acid azide were labelled by click chemistry using an alkyne-800 
infrared dye. Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose 
membranes. Representative images are shown: click chemistry signal (Top, Alk IR800), GFP (Middle, 
IR680), and HA (Bottom, IR680) immunoblots. Graphs (bottom panel) show mean +/- SEM of 
normalised S-acylation with HA zDHHC7 (HA zD7) or HA zDHHC17 (HA zD17); filled circles 
represent individual samples (n=6 different cell samples for each condition). Statistical analysis 
(Student’s t-test) showed a significant difference between the S-acylation of WT versus the GS Linker 
mutant
 
by zDHHC7 (***, p<0.001) whereas there was no significant difference of the S-acylation of 
WT versus the GS Linker mutant by zDHHC17. C. HEK293T cells were transfected with either 
EGFP SNAP25b WT (GFP S25b WT), GS Linker mutant (GFP S25 GS Linker) or a GFP control 
plasmid together with HA zDHHC17 (+ HA zD17). Lysates (Right panel, Input) were 
immunoprecipitated (IP) with a GFP antibody (Left panel), separated by SDS-PAGE and transferred 
to nitrocellulose membranes. Membranes were probed with GFP (Top, IR800) and HA (Bottom, 
IR680) antibodies. The ratio between the HA signal and the GFP signal was quantified for the 
immunoprecipitated samples and is indicated at the bottom. D. HEK293T cells were co-transfected 
with a plasmid encoding EGFP SNAP25b GS Linker (GFP S25b GS Linker) together with a plasmid 
encoding HA zDHHC17 (+ HA zD17). Cells were metabolically labelled with C16:0 azide followed 
by click chemistry using an alkyne-800 infrared dye (Alk-IR800). Cell samples were then 
concentrated by acetone precipitation, aliquoted and incubated with an equal volume of either 2M 
hydroxylamine (+ NH2OH) or 2M Tris (- NH2OH) for 1h at room temperature. They were then 
resolved and analysed by SDS PAGE. The left panel shows the click chemistry signal (Alk-IR800) 
whereas the right panel shows the anti GFP immunoblot (IR680). Position of molecular weight 
markers (in kDa) are shown on the right or left side of all immunoblots. 
Figure 6. Replacing the linker region of SNAP25 with a flexible linker does not affect its 
localisation in PC12 cells. A. PC12 cells were transfected with either EGFP SNAP25b WT (WT) or 
the GS Linker mutant (GS Linker). Cells were fractioned into cytosol (C) and membrane (M) 
fractions. Samples were separated by SDS-PAGE and transferred to nitrocellulose membranes. 
Representative images are shown (Left panel): GFP (Top, IR680), Hsp90 (Middle, IR800) and 
Syntaxin1a (Bottom, IR800). Position of molecular weight markers (in kDa) are shown on the left side 
of all immunoblots. The graph (Right panel) shows mean +/- SEM of the cytosol versus membrane 
distribution of the EGFP-tagged proteins; filled circles represent individual samples (n=4 
fractionations for each condition). Statistical analysis (Student’s t-test) showed no significant 
difference in the distribution of both constructs. B. PC12 cells were transfected with either EGFP 
SNAP25b WT (GFP S25b WT) or the GS Linker mutant (GFP S25b GS Linker) together with a 
mCHERRY SNAP25b WT plasmid (CHERRY S25 WT). The middle panel shows the localisation of 
the WT mCHERRY-tagged SNAP25b and the left panel the expression of the co-expressed WT or 
mutant EGFP-tagged SNAP25b proteins. Scale bars represent 5 μm. The graph (Right panel) 
represents mean +/- SEM of the Pearson’s co-localisation coefficient of the GFP signal versus 
mCHERRY signal for both conditions; filled circles represent individual images (n=7 cells for each 
condition). Statistical analysis (Student’s t-test) showed no significant difference between the two 
constructs.  
Figure 7. Increasing the affinity of SNAP25b for zDHHC17 results in decreased S-acylation. A. 
Amino acids within the zDABM of SNAP25 were mutated (underlined) according to the Lemonidis 
Favourable Peptide (LFP) sequence to increase its affinity for zDHHC17. B. HEK293T cells were 
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transfected with either EGFP SNAP25b WT (WT) or the LFP mutant (LFP) together with HA 
zDHHC17 (+ HA zD17). Lysates (Input) were immunoprecipitated (IP) with a GFP antibody, 
separated by SDS-PAGE and transferred to nitrocellulose membranes. Representative images are 
shown on the left panel. Membranes were probed with GFP (Top, IR800) or HA (Bottom, IR680) 
antibodies. The ratio between the HA signal and the GFP signal was quantified for the 
immunoprecipitated samples. The graph (Right panel) shows mean +/- SEM of this ratio; filled circles 
represent individual samples (n=3 immunoprecipitations from different cells for each condition). 
Statistical analysis (Student’s t-test) showed a significant difference between the interaction of 
zDHHC17 with SNAP25 WT versus the LFP mutant (**, p<0.01). C. HEK293T cells were 
transfected with either EGFP SNAP25b WT (GFP S25b WT) or the LFP mutant (LFP) together with 
either a plasmid encoding HA zDHHC7 (+ HA zD7), HA zDHHC17 (+ HA zD17) or a control pEF-
BOS HA plasmid (- HA zD7, - HA zD17). Cells were then incubated with C16:0-azide and proteins 
incorporating the fatty acid azide were labelled by click chemistry using an alkyne-800 infrared dye. 
Isolated proteins were resolved by SDS-PAGE and transferred to nitrocellulose membranes. 
Representative images are shown (Top panel): click chemistry signal (Top, Alk IR800), GFP (Middle, 
IR680) and HA (Bottom, IR680) immunoblots. Graphs (bottom panel) show mean +/- SEM of 
normalised S-acylation with HA zDHHC7 (+ HA zD7) or HA zDHHC17 (+ HA zD17); filled circles 
represent individual samples (n=6 different cell samples for each condition). Statistical analysis 
(Student’s t-test) showed no significant difference between the S-acylation of WT versus LFP
 
by 
zDHHC7 whereas there was a significant difference of the S-acylation of WT versus LFP by 
zDHHC17 (***, p<0.001). D. HEK293T cells were co-transfected with a plasmid encoding EGFP 
SNAP25b LFP (GFP S25b LFP) together with a plasmid encoding HA zDHHC17 (+ HA zD17). Cells 
were metabolically labelled with C16:0 azide followed by click chemistry using an alkyne-800 
infrared dye (Alk-IR800). Cell samples were then concentrated by acetone precipitation, aliquoted 
and incubated with an equal volume of either 2M hydroxylamine (+ NH2OH) or 2M Tris (- NH2OH) 
for 1h at room temperature. They were then resolved and analysed by SDS PAGE. The left panel 
shows the click chemistry signal (Alk-IR800) whereas the right panel shows the anti GFP immunoblot 
(IR680). Position of molecular weight markers (in kDa) are shown on the right or left side of all 
immunoblots. 
Figure 8. Modifying the length of the mini linker affects SNAP25 membrane association in PC12 
cells whereas increasing its affinity for zDHHC17 does not. A. PC12 cells were transfected with 
either EGFP SNAP25b WT (WT), or the following mutants:  ∆(101-108), (AP)6 or LFP. Cells were 
fractioned into cytosol (C) and membrane (M) fractions. Samples were separated by SDS-PAGE and 
transferred to nitrocellulose membranes. Representative images are shown: GFP (Top, IR680), Hsp90 
(Middle, IR680) and Syntaxin (Bottom, IR680). Position of molecular weight markers are shown on 
the left side of all immunoblots. The graph (bottom panel) shows mean +/- SEM of the cytosol versus 
membrane distribution of the EGFP-tagged proteins; filled circles represent individual samples (n=6 
different fractionations for each condition). Statistical analysis (ANOVA) showed a significant 
difference for the membrane association of GFP SNAP25 WT versus ∆(101-108) (***, p<0.001) and 
(AP)6 (**, p<0.01). B. PC12 cells were transfected with either EGFP SNAP25b WT (GFP S25b WT) 
or the ∆(101-108) mutant (GFP S25b ∆(101-108)) together with a mCHERRY SNAP25b WT plasmid 
(CHERRY S25b WT). The middle panels shows the localisation of the WT mCHERRY-tagged 
SNAP25b and the left panels the expression of the co-expressed WT or mutant EGFP-tagged 
SNAP25b proteins. The right panels represent the merged image with GFP SNAP25b WT and mutant 
proteins in green and CHERRY SNAP25b WT protein in red. Scale bars represent 5 μm. The graph 
(Bottom right panel) represents mean +/- SEM of the Pearson’s coefficient of the GFP signal versus 
mCHERRY signal for both constructs; filled circles represent individual images (n=5-7 cells for each 
condition). Statistical analysis (Student’s t-test) showed a significant difference between the 
localisation of the WT protein versus the ∆(101-108) deletion mutant (**, p<0.01). The 2 bottom 
confocal images are displayed with the LUT ICA which is proportional to the intensity of 
fluorescence. These images were taken from the same cells as above (cells co-expressing GFP S25b 
∆(101-108) and CHERRY S25b WT) but at a different depth within the cells in order to visualize the 
Golgi region (manually drawn on the GFP S25b ∆(101-108) image). This pseudo-colouring highlights 
the accumulation of the ∆(101-108) deletion mutant in the Golgi region of the cells. 
 








